which glp 1 does serena williams use paid endorsement for a GLP-1 company got a lot of attention but I feel the real issues were not discussed. Whether she had complications of obesity is important. GLP-1s have Why Serena Williams Went Public

Edelman has taught at both Harvard and Brown University Medical Schools, and served as a clinical consultant at the Massachusetts General Hospital

Arguments for Game Changer Status Several compelling arguments support the characterization of GLP-1 agonists as transformative therapies: Unprecedented Efficacy : Tirzepatide marks a new era in overweight/obesity treatment, enabling many to achieve 20% weight loss [76] [77]

Using a muffin tin: made the easiest pre-portioned servings

Thats why the results of recent clinical trials were surprising and welcome for some: In study after study, injected GLP-1 weight loss medications appear to work better on average for women than they do for men

De hecho, las guas KDIGO para el manejo de pacientes con diabetes y ERC posicionan a los arGLP-1 como segunda lnea de tratamiento y los indican para pacientes con DM2 y ERC que no han alcanzado los objetivos glucmicos individualizados a pesar del uso de metformina e iSGLT2, o en los que no pueden utilizar estos medicamentos porque liraglutida, semaglutida y dulaglutida (no se haban publicado los resultados con epfeglenatida) han demostrado beneficios cardiovasculares, especialmente entre pacientes con enfermedad cardiovascular establecida, asociado a beneficios renales favorables con una reduccin sustancial de la albuminuria y probable preservacin del FGe112, as como otras guias en pacientes con DM2 y riesgo cardiovascular alto/muy alto, como son los pacientes con ERD19,113